Mobile
Search
Advanced search
Multi-criteria search
Who are we ?
Log in
Sign up
Français
English
Kusajili – Clinical trials directory
Result
of your search per sponsor: gsk
gsk
Update Il y a 5 ans
A Study to Assess the Effectiveness and Tolerance of Paroxetine in the Treatment of Depression by Double-Blind Comparison with Imipramine
Country
None
organs
None
Specialty
None
Closed trial
More information
gsk
Update Il y a 5 ans
Single-Dose Bioequivalence of WELLBUTRIN® Sustained-Release Tablets Versus WELLBUTRIN Immediate-Release Tablets in Healthy Male Volunteers: A Pilot Study
Country
None
organs
None
Specialty
None
Closed trial
More information
gsk
Update Il y a 5 ans
Early clinical evaluation of a new antidepressant: A double-blind parallel study comparing paroxetine 30mg daily with amitriptyline 150mg daily
Country
None
organs
None
Specialty
None
Closed trial
More information
Woman and Man Max 99 years
gsk
Update Il y a 5 ans
Efficacy and safety of HIV Vaccine 732462 in ART-naïve HIV-1 infected persons
This study is designed to determine whether administration of the GSK Biologicals HIV vaccine 732462 can lead to a reduction in viral load, and impact on the course of human immunodeficiency virus typ...
Country
None
organs
None
Specialty
None
Closed trial
More information
Woman and Man Max 99 years
gsk
Update Il y a 5 ans
A Single-Center, Evaluator-Blinded, Randomized, Placebo Controlled, Phase 1 Clinical Trial Evaluating The Phototoxic Potential Of Topically Applied Clindamycin 1.0% - Tretinoin 0.025% Gel (Ct Gel) In Healthy Volunteers
Clindamycin 1.0% - tretinoin 0.025% gel (CT Gel) is a reformulation of VELAC Gel that contains the same active ingredients (clindamycin 1.0% and tretinoin 0.025%) in a modified vehicle. This was a sin...
Country
None
organs
None
Specialty
None
Closed trial
More information
gsk
Update Il y a 5 ans
A Multicenter, Double-blind, Placebo-controlled Fixed-dose Evaluation of Four Doses of Paroxetine
Country
None
organs
None
Specialty
None
Closed trial
More information
Woman and Man Max 99 years
gsk
Update Il y a 5 ans
PAZOPANIB FOR THE FIRST AND SECOND LINE TREATMENT OF ADVANCED STAGE PATIENTS WITH GOOD TO INTERMEDIATE RISK RENAL CELL CARCINOMIA: A COST MINIMIZATION ANALYSIS
The indirect statistical comparisons between pazopanib and the comparators will be performed using two unique approaches. The first indirecrt comparsion will be a meta-regression analysis on all the r...
Country
None
organs
None
Specialty
None
Closed trial
More information
Woman and Man Max 99 years
gsk
Update Il y a 5 ans
PRJ2335: An Observational Study of the Risk of Acute Pancreatitis in Subjects Exposed to Albiglutide, Other GLP-1 Agonists and DPP-4 Inhibitors Compared to Other Antidiabetic Agents
The role of glucagon-like peptide-1 (GLP-1) agonists in type 2 diabetes (T2D) treatment is still evolving and a number of GLP-1 agonists are newly marketed (e.g., albiglutide and lixisenatide) or in t...
Country
None
organs
None
Specialty
None
Closed trial
More information
gsk
Update Il y a 5 ans
Thiazolidinediones and coronary heart disease in a US health insurance database
Country
None
organs
None
Specialty
None
Closed trial
More information
gsk
Update Il y a 5 ans
Study to compare immunogenicity and reactogenicity of GSK Bio’s DTPa-IPV vaccine, with GSK Bio’s DTPa (Infanrix) and Aventis MSDs IPV vaccine (Imovax Polio) administered separately to healthy children 4 to 6 years of age
Country
None
organs
None
Specialty
None
Closed trial
More information
Previous
7
8
9
10
11
12
13
14
15
16
Next